1. 竹谷健, 小山千草, 小田泰昭. 血液疾患における間葉系幹細胞治療. 血液内科. 2020, 80(1) : 135-141.
2. Okawa R, Kokomoto K, Kitaoka T, Kubota T, Watanabe A, Taketani T, Michigami, T, Ozono K, Nakano K. Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types. PLoS One. 2019 Oct 10;14(10):e0222931. doi:10.1371/journal.pone.0222931.
3. Nakano C, Kitabatake Y, Takeyari S, Ohata Y, Kubota T, Taketani T, Kogo M, Ozono K. Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro. Mol Genet Metab. 2019 Jun;127(2):158-165. doi: 10.1016/j.ymgme.2019.05.014.
4. Ueno Y, Fujisaki K, Hosoda S, Amemiya Y, Okazaki S, Notsu C, Nishiyama C, Mabuchi Y, Matsuzaki Y, Oda A, Goitsuka R. Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen. Sci Rep. 2019 Dec 31;9(1):20408.
5. Mashimo T, Sato Y, Akita D, Toriumi T, Namaki S, Matsuzaki Y, Yonehara Y, Honda M. Bone marrow-derived mesenchymal stem cells enhance bone marrow regeneration in dental extraction sockets. J Oral Sci. 2019;61(2):284-293.
6. Bai Y, Sha J, Kanno T, Miyamoto K, Hideshima K, Matsuzaki Y. Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes. J Invest Surg. 2019 May 23:1-14.
7. Sha J, Kanno T, Miyamoto K, Bai Y, Hideshima K, Matsuzaki Y. Application of a Bioactive/Bioresorbable Three-Dimensional Porous Uncalcined and Unsintered Hydroxyapatite/Poly-D/L-lactide Composite with Human Mesenchymal Stem Cells for Bone Regeneration in Maxillofacial Surgery: A Pilot Animal Study. Materials(Basel). 2019 Feb 27;12(5).